Literature DB >> 30584066

Pulmonary Thromboses in Pediatric Acute Respiratory Distress Syndrome.

Magalie Caudron1, Tanya Holt2, Geoff DE Cuvelier3, Jeffrey Dmytrowich2, Gregory Hansen4.   

Abstract

Pediatric ARDS continues to be a management challenge in the ICU with prolonged hospitalizations and high mortality. Thromboembolic pulmonary embolism and in situ pulmonary artery thrombosis might represent underappreciated thrombotic processes for a subset of these patients. Although well described in the adult literature, descriptions of pulmonary thromboses with pediatric ARDS are limited to case reports. However, many risk factors for pulmonary thromboses are present in children with ARDS (eg, coagulopathy, endothelial injury, central venous catheters, concomitant inflammatory diseases), suggesting a much higher incidence is plausible. Based on an interpretation of animal, pediatric, and adult data, we propose a diagnostic algorithm to facilitate a timely and accurate diagnosis. Observing an alveolar dead space fraction ≥ 0.25, or either a 50% increase in physiologic dead space/tidal volume or a central venous saturation ≤ 60% over 24 h, triggers the algorithm. Together with targeted heparin treatment and right ventricular afterload reduction, clinical outcomes might improve if this particular patient subgroup can be identified early. While anticoagulation is recommended in adults with confirmed pulmonary embolism and low early mortality risk, data for children are limited.
Copyright © 2019 by Daedalus Enterprises.

Entities:  

Keywords:  acute respiratory distress syndrome; pediatrics; pulmonary embolism; thrombosis

Mesh:

Year:  2018        PMID: 30584066     DOI: 10.4187/respcare.06106

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  1 in total

1.  The Association Between Alveolar Dead Space Fraction and Mortality in Pediatric Acute Respiratory Distress Syndrome: A Prospective Cohort Study.

Authors:  Sheow Boon Oh; Apollo Aguilan; Herng Lee Tan; Yi-Jyun Ma; Rehena Sultana; Jan Hau Lee; Judith Ju Ming Wong
Journal:  Front Pediatr       Date:  2022-02-28       Impact factor: 3.418

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.